SEMPREXD (Actient Pharmaceuticals, LLC)
Welcome to the PulseAid listing for the SEMPREX drug offered from Actient Pharmaceuticals, LLC. This Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC],Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actient Pharmaceuticals, LLC |
| NON-PROPRIETARY NAME: | acrivastine and pseudoephedrine hydrochloride |
| SUBSTANCE NAME: | ACRIVASTINE; PSEUDOEPHEDRINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC],Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-01-26 |
| END MARKETING DATE: | 0000-00-00 |
SEMPREX D HUMAN PRESCRIPTION DRUG Details:
| Item Description | SEMPREX D from Actient Pharmaceuticals, LLC |
| LABELER NAME: | Actient Pharmaceuticals, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 8; 60(mg/1; mg/1) |
| START MARKETING DATE: | 2012-01-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 52244-404_84b92035-190d-4a3b-90de-12fba1c0bb4a |
| PRODUCT NDC: | 52244-404 |
| APPLICATION NUMBER: | NDA019806 |
Other ACRIVASTINE; PSEUDOEPHEDRINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
